These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12889538)

  • 1. Interaction of quinidine, disopyramide and metoprolol with melanin in vitro in relation to drug-induced ocular toxicity.
    Buszman E; Rózańska R
    Pharmazie; 2003 Jul; 58(7):507-11. PubMed ID: 12889538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of thioridazine with ocular melanin in vitro.
    Buszman E; Rózańska R
    Acta Pol Pharm; 2003; 60(4):257-61. PubMed ID: 14714852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of chlorpromazine, fluphenazine and trifluoperazine with ocular and synthetic melanin in vitro.
    Buszman E; Beberok A; Rózańska R; Orzechowska A
    Pharmazie; 2008 May; 63(5):372-6. PubMed ID: 18557422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of neomycin, tobramycin and amikacin with melanin in vitro in relation to aminoglycosides-induced ototoxicity.
    Buszman E; Wrześniok D; Trzcionka J
    Pharmazie; 2007 Mar; 62(3):210-5. PubMed ID: 17416198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanin counter act puromycin-induced inhibition of collagen and DNA biosynthesis in human skin fibroblasts.
    Wrześniok D; Surazyński A; Karna E; Buszman E; Pałka J
    Life Sci; 2005 Jun; 77(5):528-38. PubMed ID: 15904670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanin potentiates kanamycin-induced inhibition of collagen biosynthesis in human skin fibroblasts.
    Wrześniok D; Buszman E; Karna E; Pałka J
    Pharmazie; 2005 Jun; 60(6):439-43. PubMed ID: 15997833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.
    Debing I; Ijzerman AP; Vauquelin G
    Mol Pharmacol; 1988 Apr; 33(4):470-6. PubMed ID: 3357487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation of Ocular Melanin Drug Binding Assays. Alternatives to the Model of Multiple Classes of Independent Sites.
    Manzanares JA; Rimpelä AK; Urtti A
    Mol Pharm; 2016 Apr; 13(4):1251-7. PubMed ID: 26820602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amikacin, kanamycin and tobramycin binding to melanin in the presence of Ca(2+) and Mg(2+) ions.
    Wrześniok D; Buszman E; Miernik-Biela E
    Acta Pol Pharm; 2012; 69(6):1035-41. PubMed ID: 23285663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [UV-Vis spectroscopic study of aluminum-manganese cooperative effect on the melanin formation from DOPA oxidation].
    Di Jun-Wei ; Bi SP
    Guang Pu Xue Yu Guang Pu Fen Xi; 2005 Jan; 25(1):83-5. PubMed ID: 15852826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of the melanin binding of p-bromo-methylamphetamine (V-111).
    Báthory G; Szökö E; Magyar K; Deutsch T
    Pol J Pharmacol Pharm; 1990; 42(1):19-27. PubMed ID: 2281018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the mechanism of chloroquine binding to synthetic DOPA-melanin.
    Stepień KB; Wilczok T
    Biochem Pharmacol; 1982 Nov; 31(21):3359-65. PubMed ID: 6816244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid-chromatographic determination of antidysrhythmic drugs: procainamide, lidocaine, quinidine, disopyramide, and propranolol.
    Kabra PM; Chen SH; Marton LJ
    Ther Drug Monit; 1981; 3(1):91-101. PubMed ID: 7233493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative comparison of the anticholinergic and antiarrhytmic actions of disopyramide and quinidine.
    Pérez A; Ledea N; Hermández K; Garcia-Barreto D
    Pol J Pharmacol Pharm; 1977; 29(5):527-32. PubMed ID: 593967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of drugs to eye melanin is not predictive of ocular toxicity.
    Leblanc B; Jezequel S; Davies T; Hanton G; Taradach C
    Regul Toxicol Pharmacol; 1998 Oct; 28(2):124-32. PubMed ID: 9927562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of flavins with melanin. Studies on equilibrium binding of riboflavin to dopa-melanin and some spectroscopic characteristics of flavin-melanin complex.
    Kozik A; Korytowski W; Sarna T; Bloom AS
    Biophys Chem; 1990 Oct; 38(1-2):39-48. PubMed ID: 2128193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.
    Lima JJ; Boudoulas H; Blanford M
    J Pharmacol Exp Ther; 1981 Dec; 219(3):741-7. PubMed ID: 7299695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of metal ions on netilmicin-melanin interaction.
    Wrześniok D; Buszman E; Grzegorczyk M; Grzegorczyk A; Hryniewicz T
    Acta Pol Pharm; 2012; 69(1):41-5. PubMed ID: 22574505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding affinity of bunazosin, dorzolamide, and timolol to synthetic melanin.
    Kiuchi Y; Terakawa N; Nakata T; Yamasaki K; Saito Y; Ito N; Okada K
    Jpn J Ophthalmol; 2004; 48(1):34-6. PubMed ID: 14767648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of [3H]flunitrazepam binding to melanin.
    Testorf MF; Kronstrand R; Svensson SP; Lundström I; Ahlner J
    Anal Biochem; 2001 Nov; 298(2):259-64. PubMed ID: 11700981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.